Zurich Insurance Group AG (OTCMKTS:ZURVY) Corporate Logo

ZURICH INSURANCE GROUP LTD SPONSORED (OTCMKTS:ZURVY) recorded an increase of 32.45% in shorted shares. FINRA issued in December ZURVY’s total 60,000 shorted shares. The up change of 32.45% from 45,300 shares was reported. ZURICH INSURANCE GROUP LTD SPONSORED (OTCMKTS:ZURVY) has 144,400 shares average volume. It’ll cost 0 days for ZURVY to recover its previous position.

ZURVY hit $30.09 during the last trading session after $0.18 change.Zurich Insurance Group AG is after having 0.00% since December 8, 2017. ZURVY has 90,467 volume or 2.54% up from normal. ZURVY underperformed the S&P 500 by 15.62%.

Zurich Insurance Group AG, together with its subsidiaries, provides insurance products and related services in Europe, North America, Latin America, and the Asia Pacific.The firm is valued at $45.13 billion. The firm operates through Property & Casualty Regions, Life Regions, Farmers, and Non-Core Businesses divisions.13.75 is the P/E ratio. It offers car, home, travel, general liability, life and critical illness, and other insurance products; and saving and investment, and pension and retirement planning products.

For more Zurich Insurance Group AG (OTCMKTS:ZURVY) news published briefly go to: Seekingalpha.com, Seekingalpha.com, Seekingalpha.com, Seekingalpha.com or Seekingalpha.com. The titles are as follows: “Generali: An Undervalued Insurance Company Offering Restructuring And Growth – Seeking Alpha” published on December 02, 2016, “Zurich Insurance (ZURVY) Investor Presentation – Slideshow – Seeking Alpha” on November 16, 2017, “AXA Delivering On Its Pledges, And The Market Is Starting To Notice – Seeking Alpha” with a publish date: October 08, 2018, “AXA: An Undervalued Income Play Which May Re-Rate In The Short Term – Seeking Alpha” and the last “Buy Zurich For Its 5.7% Yield – Seeking Alpha” with publication date: November 22, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.